drugset / Trial / NCT07290400

Effect of Moderate Alcohol on Absorption and Onset of Hezkue Sildenafil Suspension

NCT07290400

Phase 2 Not yet recruiting 36 enrolled Aspargo Labs, Inc
RandomizedCrossoverOpen-labelTreatment

Summary

This is a Phase 2, open-label, randomized crossover study assessing the effect of moderate alcohol intake on the absorption and onset of action of Hezkue® sildenafil oral suspension in adult subjects. Participants will receive Hezkue® under different alcohol intake conditions in randomized sequence. Pharmacokinetic sampling and onset assessments will be performed after each administration, and safety will be monitored throughout the study.

Timeline

Start
2026-04-15
Primary completion
2026-06-15
Completion
2026-06-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Sildenafil Unknown Oral

Indications